Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-22-000966
Filing Date
2022-04-01
Accepted
2022-04-01 16:33:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS cvs3990751-defa14a.htm DEFA14A 38298
2 GRAPHIC cvs3990751-defa14ax1x1.jpg GRAPHIC 62129
3 GRAPHIC cvs3990751-defa14ax1x2.jpg GRAPHIC 5163
4 GRAPHIC cvs3990751-defa14ax1x3.jpg GRAPHIC 3186
5 GRAPHIC cvs3990751-defa14ax1x4.jpg GRAPHIC 7360
6 GRAPHIC cvs3990751-defa14ax1x5.jpg GRAPHIC 6948
7 GRAPHIC cvs3990751-defa14ax2x1.jpg GRAPHIC 1098
8 GRAPHIC cvs3990751-defa14ax2x2.jpg GRAPHIC 1091
9 GRAPHIC cvs3990751-defa14ax3x1.jpg GRAPHIC 6956
  Complete submission text file 0001206774-22-000966.txt   170171
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-01011 | Film No.: 22798801
SIC: 5912 Retail-Drug Stores and Proprietary Stores